- Home
- XBIO vs APDN Comparison
XBIO vs APDN Comparison
Compare XBIO & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIO
- APDN
- Stock Information
- Founded
- XBIO N/A
- APDN 1983
- Country
- XBIO United States
- APDN United States
- Employees
- XBIO N/A
- APDN N/A
- Industry
- XBIO Biotechnology: Pharmaceutical Preparations
- APDN Other Consumer Services
- Sector
- XBIO Health Care
- APDN Consumer Discretionary
- Exchange
- XBIO Nasdaq
- APDN Nasdaq
- Market Cap
- XBIO 4.2M
- APDN 4.2M
- IPO Year
- XBIO N/A
- APDN N/A
- Fundamental
- Price
- XBIO $3.53
- APDN $4.98
- Analyst Decision
- XBIO Hold
- APDN
- Analyst Count
- XBIO 1
- APDN 0
- Target Price
- XBIO N/A
- APDN N/A
- AVG Volume (30 Days)
- XBIO 169.6K
- APDN 129.1K
- Earning Date
- XBIO 08-12-2025
- APDN 08-07-2025
- Dividend Yield
- XBIO N/A
- APDN N/A
- EPS Growth
- XBIO N/A
- APDN N/A
- EPS
- XBIO N/A
- APDN N/A
- Revenue
- XBIO $2,582,728.00
- APDN $3,790,616.00
- Revenue This Year
- XBIO $14.23
- APDN $57.08
- Revenue Next Year
- XBIO $7.14
- APDN $40.00
- P/E Ratio
- XBIO N/A
- APDN N/A
- Revenue Growth
- XBIO 5.63
- APDN N/A
- 52 Week Low
- XBIO $2.20
- APDN $4.37
- 52 Week High
- XBIO $5.27
- APDN $2,655.00
- Technical
- Relative Strength Index (RSI)
- XBIO 58.63
- APDN 29.27
- Support Level
- XBIO $2.65
- APDN $4.44
- Resistance Level
- XBIO $5.27
- APDN $5.50
- Average True Range (ATR)
- XBIO 0.45
- APDN 0.56
- MACD
- XBIO 0.09
- APDN 0.46
- Stochastic Oscillator
- XBIO 33.61
- APDN 7.42
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.